Patents

Creative BioTherapeutics is dedicated to find novel therapies to the world’s diseases. Our extensive list of patents proves the dedication to this cause.

U.S.10,905,750 Granted February 2, 2021, “GRP78 Antagonist That Block binding of Receptor Tyrosine Kinase Orphan Receptors as Immunotherapy Anticancer Agents”, Donald J Davidson

WO 9741824 “Kringle 5, a Novel Antiangiogenic Inhibitor”, Donald J. Davidson.

U.S.5801146 “Compound and Method for Inhibiting Angiogenesis”, Donald J. Davidson

U.S.5981484 “Novel Antiangiogenic Peptides, and Methods for Inhibiting Angiogenesis“  D.J. Davidson, G. Shepard, K. Megumi, J. Henkin

U.S.5972896 “Anti-Angiogenic Peptides and Methods for Inhibition Angiogenesis”, Donald J. Davidson,

U.S.6057122 “Anti-Angiogenic Peptides and Polynucleotides Encoding the same and Methods for Inhibiting Angiogenesis”, Donald J. Davidson

U.S.6150362 “Triazine Angiogenesis Inhibitors” Donald J. Davidson, J.Henkin,         

U.S.20040138127 “Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis”, Davidson, Donald J.; Wang, Jieyi; Gubbins, Earl, J.

U.S.6699838 “Antiangiogenic peptides”, Donald J. Davidson

U.S.6251867 “Antiangiogenic peptides and methods for inhibiting angiogenesis”, Davidson, Donald J.

U.S.6288228 B1 “Triazine Angiogenesis Inhibitors”, Davidson, Donald J. Henkin, Jack, Sheppard, George S., Woods, Keith, McCroskey, Richard.

U.S. Application number 2005/0053993 A1 “Uses of an endothelial cell receptor”, Donald J. Davidson

WO 2008076868 A2 “Methods and Compositions Related to Modulation of Receptor Tyrosine Kinase Receptor-1”, Donald J. Davidson, Catherine Haskell

U.S. Application Number:  2017/US 62/584,564 “Anticancer proteins having a kringle 5 subunit.” Donald J Davidson